A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial

Jonathan P. Piccini, Stuart J. Connolly, William T. Abraham, Jeff S. Healey, Benjamin A. Steinberg, Hussein R. Al-Khalidi, Patricia Dignacco, Dirk J. van Veldhuisen, William H. Sauer, Michel White, Stephen B. Wilton, Inder S. Anand, Christopher Dufton, Debra A. Marshall, Ryan G. Aleong, Gordon W. Davis, Richard L. Clark, Laura L. Emery, Michael R. Bristow

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial'. Together they form a unique fingerprint.

Medicine & Life Sciences